Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D2-like receptor agonist quinpirole

European Journal of Pharmacology

Volumn 395, Issue 2, 2000, Pages 157-160

  D'Aquila, Paolo S ^a   Collu, Maria ^b   Devoto, Paola ^b   Serra, Gino ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antidepressant drug; Imipramine; Lithium chloride; Locomotor activity; Mania

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; LITHIUM CHLORIDE; QUINPIROLE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LITHIUM BLOOD LEVEL; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SUPERSENSITIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; DOPAMINE AGONISTS; DRUG INTERACTIONS; IMIPRAMINE; LITHIUM CHLORIDE; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 0034724845     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00189-8     Document Type: Article

References (19)

1. Arriaga F., Dugovic C., Wauquier A. Effects of lithium on dopamine behavioural supersensitivity induced by rapid eye movement sleep deprivation. Neuropsychobiology. 20:1988;23-27.
2. Baldessarini R.J. Drugs and the treatment of psychiatric disorders - depression and mania. Hardman J.G., Limbird L.E. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edn. 1996;431-459 McGraw-Hill, New York.
3. Bloom F.E., Baetge G., Deyo S., Ettenberg A., Koda L., Magistretti P.J., Shoemaker W.J., Staunton D.A. Chemical and physiological aspects of the actions of lithium and antidepressant drugs. Neuropharmacology. 22(3):1983;359-365. Spec. No.
4. 2-like receptor stimulation induced by repeated electroconvulsive shock. J. Psychopharmacol. 11:1997;41-44.
5. Das Chagas Rodrigues F., Zwicker A.P., Calil H.M. Chronic lithium prevents REM-sleep deprivation-induced increased responsiveness to apomorphine. J. Pharm. Pharmacol. 37:1985;210-211.
6. Dehpour A.R., Samini M., Sharifzadeh M., Hasan Mazandarani H. Effects of chronic lithium pretreatment on apomorphine-induced penile erection. Gen. Pharmacol. 26:1995;1015-1020.
7. Dehpour A.R., Samini M., Aliebrahimi F., Chavoushzadeh M.A. The effect of acute lithium and rubidium pretreatment on apomorphine-induced pecking in pigeons. Pharmacol. Toxicol. 82:1998;147-152.
8. Ebstein R.P., Eliashar S., Belmaker R.H., Ben Uriah Y., Yehuda S. Chronic lithium treatment and dopamine-mediated behavior. Biol. Psychiatry. 15:1980;459-467.
9. Gessa G.L., Canu A., Del Zompo M., Burrai C., Serra G. Lack of acute antipsychotic effect of SCH 23390, a selective dopamine D1 receptor agonist. Lancet. 337:1991;854-855.
10. Gessa G.L., Pani L., Fadda P., Fratta W. Sleep deprivation in the rat: an animal model of mania. Eur. Neuropsychopharmacol. 5:1995;89-93. Suppl.
11. Gruenthal M. Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine. Brain Res. 306:1984;189-196.
12. Koukopoulos A., Reginaldi D., Minnai G., Serra G., Pani L., Johnson F.N. The long term profilaxis of affective disorders. Gessa G.L., Fratta W., Pani L., Serra G. Depression and Mania: from Neurobiology to treatment. Adv. Biochem. Psychopharmacol. vol. 49:1995;127-147 Raven Press, New York.
13. Nixon M.K., Hascoet M., Bourin M., Colombel M.C. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology. 115:1994;59-64.
14. Pittman K.J., Jakubovic A., Fibiger H.C. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology. 82:1984;371-377.
15. Rubin E.H., Wooten G.F. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology. 84:1984;217-220.
16. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Res. 527:1990;234-243.
17. Serra G., Collu M., D'Aquila P.S., Gessa G.L. Role of the mesolimbic system in the mechanism of action of antidepressants. Pharmacol. Toxicol. 71(Suppl. 1):1992;72-85.
18. Swerdlow N.R., Lee D., Koob G.F., Vaccarino F.J. Effects of chronic dietary lithium on behavioural indices of dopamine denervation supersensitivity in the rat. J. Pharmacol. Exp. Ther. 235:1985;324-339.
19. Winer B.J. Statistical Principles in Experimental Design. 1971;McGraw-Hill, London.